Company / Share Buybacks
Exelixis Share Buybacks History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$947.5M
FY2025
5-year range
$550.4M / $947.5M
FY2023-FY2025
Trend
+45.3%
vs FY2024
Sector context
#10 of 48
Health Care
What the data says
Exelixis's share buybacks of $948M is higher than 79% of companies in the Health Care sector (FY2025). Improved from $550M to $948M over the past 2 years.
Based on SEC 10-K filings.
$948M in FY2025. Top quartile in the Health Care sector.
Improved from $550M to $948M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 48This company $947.5M Sector average $611.9M
▼
+54.9% above sector average
Key checks
Key Insights
- In FY2025, share buybacks increased 45.3% year-over-year.
- Ranks #10 out of 48 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $947.5M | +45.3% |
| FY2024 | $652.0M | +18.5% |
| FY2023 | $550.4M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026